PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Dec 23, 2021 · Iona Everson from PMGroup spoke to John Forni, Country Medical Director at Sanofi UK & Ireland, about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK and how the government, NHS and industry can work together to …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
The alliance is aimed at advancing treatments for multiple disease areas, including oncology
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, advice ... ... News
PME - Home
How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
PME Magazine
Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!
About us - PMLiVE
DESIGN AND PRODUCTION. Hina Mistry – Designer Email: [email protected] Tel: +44 (0)1372 414 272. Anamaria Popescu – Front-End Developer Email: [email protected] Tel: +44 (0)1372 414 262
PME - Articles - Pharmaceutical Market Europe
INNOVATIVE IMPACT BLOG - Shaping tomorrow with strategic foresight in early commercialisation. How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
PME - PMLiVE
Pharmaceutical Market Europe – October 2024. Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024
Healthcare - PMLiVE
The site will be designed to accommodate multiple product types within rare diseases. Read More
PME - PMLiVE
AstraZeneca’s Lynparza recommended by NICE to treat advanced breast cancer; Sanofi and Alloy Therapeutics enter central nervous system deal worth over $427m